October 20, 2015 / 5:33 AM / 2 years ago

BRIEF-Evotec agrees cooperation on juvenile Batten disease therapies

Oct 20 (Reuters) - Evotec AG

* Evotec and Beyond Batten Disease Foundation collaborate to advance emerging therapies to fight juvenile Batten disease

* Says to develop in vivo mechanistic and efficacy assays to assess translational potential of fundamental and early drug discovery findings emerging from academic institutions in U.S. and Europe

* Collaboration includes substantial research funding to Evotec and runs to end of 2017, with an option to extend beyond this period Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below